ANN CAI ET AL: "#887 Peptides Derived From Mutated BCR-ABL Elicit T Cell Immunity In CML Patients", BLOOD, vol. 116, no. 21, 19 November 2010 (2010-11-19), pages 388-389, XP055549636, (B1)

CORY A BRENNICK ET AL: "Neoepitopes as cancer immunotherapy targets: key challenges and opportunities", IMMUNOTHERAPY, vol. 9, no. 4, 1 March 2017 (2017-03-01), pages 361-371, XP055471535, GB ISSN: 1750-743X, DOI: 10.2217/imt-2016-0146 (B1)

Feng Jiang ET AL: "Construction of Evolutionary Tree Models for Renal Cell Carcinoma from Comparative Genomic Hybridization Data", Cancer Research, 1 November 2000 (2000-11-01), pages 6503-6509, XP055549699, United States Retrieved from the Internet: URL:http://cancerres.aacrjournals.org/cont ent/60/22/6503.full-text.pdf (B1)

GIORGIO PARMIANI ET AL: "Unique human tumor antigens: immunobiology and use in clinical trials.", THE JOURNAL OF IMMUNOLOGY, vol. 178, no. 4, 1 February 2007 (2007-02-01), pages 1975-1979, XP055044894, ISSN: 0022-1767 (B1)

H-G Rammensee ET AL: "Cancer Vaccines: Some Basic Considerations" In: "Genomic and Personalized Medicine", 11 November 2008 (2008-11-11), Elsevier, XP055348899, page 573589, DOI: 10.1016/B978-0-12-369420-1.00050-0, * page 577, left-hand column, last paragraph - page 578, right-hand column, paragraph 2 * * figure 50.1 * (B1)

J. BOGOJESKA ET AL: "Rtreemix: an R package for estimating evolutionary pathways and genetic progression scores", BIOINFORMATICS., vol. 24, no. 20, 20 August 2008 (2008-08-20), pages 2391-2392, XP055549700, GB ISSN: 1367-4803, DOI: 10.1093/bioinformatics/btn410 (B1)

WO-A2-2011/143656 (B1)

NIELSEN J S ET AL: "An in vitro-transcribed-mRNA polyepitope construct encoding 32 distinct HLA class I-restricted epitopes from CMV, EBV, and Influenza for use as a functional control in human immune monitoring studies", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 360, no. 1-2, 31 August 2010 (2010-08-31), pages 149-156, XP027222180, ISSN: 0022-1759 [retrieved on 2010-07-15] (B1)

RAMMENSEE H-G ET AL: "TOWARDS PATIENT-SPECIFIC TUMOR ANTIGEN SELECTION FOR VACCINATION", IMMUNOLOGICAL REVI, WILEY-BLACKWELL PUBLISHING, INC, US, vol. 188, 1 October 2002 (2002-10-01), pages 164-176, XP008026240, ISSN: 0105-2896, DOI: 10.1034/J.1600-065X.2002.18815.X (B1)

TIMOTHY J. LEY ET AL: "DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome", NATURE, vol. 456, no. 7218, 6 November 2008 (2008-11-06), pages 66-72, XP055052871, ISSN: 0028-0836, DOI: 10.1038/nature07485 (B1)

TOBIAS SJÖBLOM ET AL: "The Consensus Coding Sequences of Human Breast and Colorectal Cancers", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, WASHINGTON, DC; US, vol. 314, 13 October 2006 (2006-10-13), pages 268-274, XP007901261, ISSN: 0036-8075, DOI: 10.1126/SCIENCE.1133427 (B1)

UGUR SAHIN ET AL: "Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer", NATURE, SPRINGER NATURE PUBLISHING AG, LONDON , vol. 547, no. 7662 13 July 2017 (2017-07-13), pages 222-226, XP002780019, ISSN: 1476-4687, DOI: 10.1038/NATURE23003 Retrieved from the Internet: URL:https://www.nature.com/articles/nature 23003.pdf [retrieved on 2017-07-05] (B1)

M. SENSI: "Unique Tumor Antigens: Evidence for Immune Control of Genome Integrity and Immunogenic Targets for T Cell-Mediated Patient-Specific Immunotherapy", CLINICAL CANCER RESEARCH, vol. 12, no. 17, 1 September 2006 (2006-09-01), pages 5023-5032, XP055094295, ISSN: 1078-0432, DOI: 10.1158/1078-0432.CCR-05-2682 (B1)